Abstract CT144: Phase I investigator-initiated clinical trial of CD19CAR -T cells secreting PD-1-targeted IL-21 in relapsed/refractory B-cell non-Hodgkin lymphoma
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Yu Jing, Ying Li, Meng Li, Shengjuan Zhang, Baocai Zhao, Yueyi An, Hang Li, Jitao Zhao, Liping Dou, Shengdian Wang
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409822174